Global Medical Device Market Access & Regulatory Pathways

Bringing an innovative medical device to patients is hard enough. Navigating different regulatory, market access, and in-country requirements across the US, EU, UK, Asia-Pacific, and emerging markets can slow launches and drain internal teams. Freyr partners with medical device and IVD manufacturers to plan, execute, and maintain global market access, from early regulatory strategy and device registration to authorized representation and ongoing lifecycle support.

420
+
Medical Device Customers
1200
+
Projects
1750
+
Device Approvals
99%
+
First-time-right Submission
120
+
Markets
52
+
Countries
70
+
Product categories supported
350
+
High Risk Device Approval
800
+
Moderate Risk Device Approval
600
+
Low Risk Device

Understanding Medical Device Market Access and How Freyr Helps Overcome Key Challenges

Medical device market access is the end-to-end process of securing regulatory approval, registration, and a sustainable presence for your devices in each target country. It spans choosing the right regulatory pathway (for example, FDA 510(k), PMA, De Novo, EU MDR/IVDR, UKCA, and other national routes), compiling technical and clinical evidence, aligning labeling and quality systems, and maintaining compliance so products can reach patients and stay on the market with predictable revenue.

However, manufacturers often face complex and fragmented requirements across regions. Typical challenges include unclear regulatory strategy, differing device classification rules, changing country-specific regulations, limited visibility into timelines, pricing, and reimbursement impact, and the need for local authorized representatives or importers. These issues can lead to delayed approvals, duplicated documentation, inconsistent dossiers, and lost commercial opportunities in key markets.

Freyr helps medical device and IVD manufacturers overcome these market access barriers through an integrated, global approach. Our experts design practical market access and regulatory strategies, prepare and manage submissions for medical device registration in 120+ countries, and provide in-country representation where required. Supported by robust regulatory and market intelligence, we anticipate changes, optimize documentation across jurisdictions, and provide post-market support, enabling you to reduce risk, accelerate launches, and scale your global presence without expanding internal regulatory headcount.

Freyr’s End-to-End Medical Device Market Access and Regulatory Support

Global Regulatory Strategy & Market Access Roadmapping

Define global medical device regulatory strategy and launch sequencing
Map optimal pathways (FDA 510(k)/PMA/De Novo, EU MDR/IVDR, UKCA, etc.)
Align design, clinical/performance evidence, and documentation with target markets
Highlight regulatory risks, dependencies, and fast-track options

Medical Device & IVD Registration Across 120+ Countries

End-to-end medical device and IVD registration in established and emerging markets
Dossier preparation, submission, and Health Authority query support
Harmonized technical documentation to minimize duplication across regions
Coordination with local reviewers to help shorten approval timelines

In-Country Representation & Authorized Representative Services

EU Authorized Representative, UKRP, CH-Rep, and other local regulatory agents
US FDA Agent, Canada importer/agent, and representation in LATAM, APAC, and RoW
Local interface for registrations, renewals, vigilance, and incident reporting
Framework that preserves your control over data, labeling, and commercial strategy

Regulatory & Market Intelligence for Market Access Decisions

Continuous tracking of global medical device regulations and guidance
Country-level regulatory and market access landscape assessments
Inputs for market prioritization, evidence planning, and launch strategy
Custom regulatory intelligence outputs to support portfolio decisions

Post-Market Surveillance & Lifecycle Market Access Support

EU MDR/IVDR-compliant PMS, PSUR, PMCF planning and reporting
Change impact assessment and submissions for design or labeling updates
License renewals, indication extensions, and geographic expansion support
Ongoing compliance monitoring to help protect approvals and market presence

Explore more about Freyr’s capabilities concerning

Discover & Prioritize

Understand your portfolio, pipeline, and business goals Identify priority markets and risk tolerance

Design Your Market Access Roadmap

Map regulatory pathways and sequence of markets
Align documentation, clinical/performance evaluation, and market intelligence

Execute Registrations & Set Up Local Footprint

Prepare and submit dossiers
Set up authorized representation / local agents
Coordinate responses to Health Authority questions

Maintain & Expand Access

Manage renewals, post-market surveillance, and change controls
Support indication expansions and entry into additional markets

Why Partner with Freyr?

End-to-end support across regulatory strategy, market access planning, registration, in-country representation, and lifecycle management.
Global footprint with coverage in 120+ countries through delivery centers and in-country affiliates.
Deep device, IVD, and SaMD expertise across all risk classes and multiple therapeutic areas.
Regulatory and market intelligence–driven approach to anticipate changes and de-risk expansion.
Proven outcomes with hundreds of approvals and a consistently high first-time-right submission rate.

Frequently Asked Questions

What does medical device market access encompass beyond device registration?

Beyond device registration, medical device market access includes defining the appropriate regulatory pathway, aligning classification and technical documentation across regions, meeting country-specific compliance requirements, establishing in-country representation, and fulfilling post-market obligations such as vigilance and surveillance. These regulatory activities ensure a device can be lawfully placed, maintained, and expanded across global markets throughout its lifecycle.

What are the key requirements for medical device registration across global markets?

Medical device registration requirements vary widely but typically involve device classification, quality system compliance, technical documentation, clinical or performance evidence, labeling reviews, and in some countries local representation. Regulations differ across FDA, MDR/IVDR, UKCA, Health Canada, NMPA, PMDA, and others. Successful registration requires harmonized documentation, awareness of national variations, and early planning for regulatory changes.

What factors most strongly influence successful market access for a new medical device?

Successful market access depends on a coherent mix of clinical effectiveness, safety, health-economic value and operational feasibility. Payers and providers look for demonstrable outcome improvements, credible comparators, transparent cost-effectiveness, and manageable implementation requirements. Manufacturers that understand decision-makers’ evidence thresholds and contextual pressures can shape development, launch sequencing and lifecycle planning around real adoption drivers rather than only regulatory milestones.

How does real-world evidence (RWE) influence medical device market access decisions?

Real-world evidence (RWE) enhances understanding of how a device performs outside controlled trial conditions, capturing diverse populations, workflow impacts, resource utilization, and longitudinal outcomes. Health systems increasingly rely on real-world data to validate claims of effectiveness or economic benefit. Strong real-world evidence can strengthen HTA submissions, support reimbursement negotiations, and help maintain market access through lifecycle assessments..

What factors most commonly delay market access for medical devices globally?

Delays often stem from misaligned evidence strategies, evolving regulatory requirements, inconsistent documentation across regions, misjudged device classification, insufficient health-economic justification, or lack of early payer engagement. Additionally, divergence in regional policies, such as MDR in Europe or coding and coverage policies in the US, can create unexpected barriers. Proactive planning and regulatory intelligence significantly reduce these risks.

Why do market access requirements vary so widely between countries?

Countries differ in regulatory pathways, health-system priorities, reimbursement models, and evidence thresholds. For example, the US separates FDA approval from payer coverage decisions, while Europe integrates CE marking with emerging joint HTA processes. Emerging markets may prioritize local clinical data, quality systems, or in-country representation. Understanding these structural differences is essential for sequencing launches and optimizing global market access strategy.

What makes Freyr a leading partner for global medical device market access?

Freyr is recognized for combining deep regulatory expertise, global in-country presence, and evidence-driven decision support across the full medical device lifecycle. Organizations often rely on Freyr when navigating multi-region pathways or scaling portfolios because of its integrated approach to strategy, registration, and compliance. This blend of global capability and technical depth consistently positions Freyr among preferred partners in market access and regulatory pathways.